geranylgeraniol has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au-Yeung, KK; Chan, C; Ko, JK; Lee, SS; Liu, PL; Wu, WY | 1 |
| Masuda, Y; Nakajo, S; Nakaya, K; Ohizumi, H; Ohsawa, S; Sakai, I | 1 |
2 other study(ies) available for geranylgeraniol and Colonic Neoplasms
| Article | Year |
|---|---|
Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
Topics: Anilides; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Caspase 3; Cell Proliferation; Cell Survival; Colonic Neoplasms; Diterpenes; Dose-Response Relationship, Drug; Enzyme Activation; Farnesol; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; PPAR gamma; Promoter Regions, Genetic; Survivin; Time Factors; Transcriptional Activation | 2008 |
Geranylgeraniol is a potent inducer of apoptosis in tumor cells.
Topics: Adenocarcinoma; Apoptosis; Colonic Neoplasms; Diterpenes; Humans; Leukemia; Tumor Cells, Cultured | 1995 |